Illuminated microcatheter significantly lowers IOP in trabeculotomy

Article

Circumferential trabeculotomy performed with an illuminated microcatheter causes a significant reduction in IOP in glaucoma patients.

Circumferential trabeculotomy performed with an illuminated microcatheter causes a significant reduction in IOP in glaucoma patients, according to a study featured in the Journal of Glaucoma.

Dr C.A. Girkin et al., Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Alabama, USA, conducted a retrospective chart study on 11 eyes from 7 patients with primary or secondary congenital or juvenile glaucoma.

All patients underwent circumferential trabeculotomy with an illuminated microcatheter and eyes with six or more months of IOP data were included in the study. An IOP of lower than 21 mmHg was considered a success and a 30% IOP reduction without the use of IOP-lowering medications was also considered a success.

Mean IOP was 33.8±6.3 preoperatively and 18.3±3.5 at the final postoperative follow-up visit. Qualified success was demonstrated in 90.1% of eyes and unqualified success was reported in 81.8% of eyes. There were no long-term surgical complications.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.